Nabriva Therapeutics plc Current Liabilities
Nabriva Therapeutics plc had Current Liabilities of $26.20 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-10-19
- 2023-06-30: Liabilities, Current $26.20M.
- 2023-03-31: Liabilities, Current $28.00M.
- 2022-12-31: Liabilities, Current $27.61M.
- 2022-09-30: Liabilities, Current $21.64M.
| Period end | Liabilities, Current |
|---|---|
| 2023-06-30 | $26.20M 10-Q · filed 2023-10-19 |
| 2023-03-31 | $28.00M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $27.61M 10-Q · filed 2023-10-19 |
| 2022-09-30 | $21.64M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $19.33M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $16.27M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $22.34M 10-K · filed 2023-04-17 |
| 2021-09-30 | $19.73M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $19.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $18.30M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $18.52M 10-K · filed 2022-03-29 |
| 2020-09-30 | $10.97M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $11.96M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $16.64M 10-K · filed 2021-03-11 |
| 2019-09-30 | $14.88M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.12M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $18.09M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $17.81M 10-K · filed 2020-03-12 |
| 2018-09-30 | $15.06M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $11.29M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $11.38M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $13.26M 10-K · filed 2019-03-12 |
| 2017-09-30 | $16.33M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $16.75M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $15.89M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $15.88M 10-K · filed 2018-03-16 |
| 2015-12-31 | $8.92M 10-K · filed 2017-03-24 |